| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.091 | 0.006 |